Clinical Trial: A Study of STAR-0215 in Participants With Hereditary Angioedema
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Hereditary Angioedema
Study Type: INTERVENTIONAL
Official Title: A Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of STAR-0215 in Participants With Heredit
Brief Summary:
The goal of this clinical trial is to test the drug STAR-0215 in participants with hereditary angioedema (HAE).One group of participants will get 1 dose of STAR-0215, and two other groups will get 2 doses of STAR-0215.Researchers will study the effects of STAR-0215 in participants with HAE as this is the first time that the drug has been given to participants with HAE.
Read more